Target Price | $273.41 |
Price | $273.03 |
Potential |
0.14%
register free of charge
|
Number of Estimates | 17 |
17 Analysts have issued a price target CME Group a 2026 .
The average CME Group a target price is $273.41.
This is
0.14%
register free of charge
$305.00
11.71%
register free of charge
$211.00
22.72%
register free of charge
|
|
A rating was issued by 20 analysts: 8 Analysts recommend CME Group a to buy, 8 to hold and 4 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the CME Group a stock has an average upside potential 2026 of
0.14%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion $ | 10.21 | 6.61 |
5.94% | 35.26% | |
EBITDA Margin | 81.76% | 71.67% |
2.08% | 12.34% | |
Net Margin | 34.10% | 58.64% |
16.19% | 71.96% |
15 Analysts have issued a sales forecast CME Group a 2025 . The average CME Group a sales estimate is
This results in the following potential growth metrics:
10 Analysts have issued an CME Group a EBITDA forecast 2025. The average CME Group a EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
8 CME Group a Analysts have issued a net profit forecast 2025. The average CME Group a net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | 9.67 | 10.78 |
9.14% | 11.48% | |
P/E | 25.33 | |
EV/Sales | 15.18 |
8 Analysts have issued a CME Group a forecast for earnings per share. The average CME Group a EPS is
This results in the following potential growth metrics and future valuations:
Analyst | Rating | Action | Date |
---|---|---|---|
Oppenheimer |
Locked
➜
Locked
|
Locked | Jun 04 2025 |
UBS |
Locked
➜
Locked
|
Locked | Apr 25 2025 |
JP Morgan |
Locked
➜
Locked
|
Locked | Apr 24 2025 |
Keefe, Bruyette & Woods |
Locked
➜
Locked
|
Locked | Apr 24 2025 |
Morgan Stanley |
Locked
➜
Locked
|
Locked | Apr 24 2025 |
Barclays |
Locked
➜
Locked
|
Locked | Apr 23 2025 |
Oppenheimer |
Locked
➜
Locked
|
Locked | Apr 11 2025 |
Analyst Rating | Date |
---|---|
Locked
Oppenheimer:
Locked
➜
Locked
|
Jun 04 2025 |
Locked
UBS:
Locked
➜
Locked
|
Apr 25 2025 |
Locked
JP Morgan:
Locked
➜
Locked
|
Apr 24 2025 |
Locked
Keefe, Bruyette & Woods:
Locked
➜
Locked
|
Apr 24 2025 |
Locked
Morgan Stanley:
Locked
➜
Locked
|
Apr 24 2025 |
Locked
Barclays:
Locked
➜
Locked
|
Apr 23 2025 |
Locked
Oppenheimer:
Locked
➜
Locked
|
Apr 11 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.